Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 229

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Changes in Androgen Receptor Nongenotropic Signaling Correlate with Transition of LNCaP Cells to Androgen Independence

Open access
Unni, Emmanual, Sun, Shihua, Nan, Bicheng, McPhaul, Michael J., Cheskis, Boris, Mancini, Michael A., Marcelli, Marco·2004·Cancer Research

Abstract

A cure for prostate cancer (CaP) will be possible only after a complete understanding of the mechanisms causing this disease to progress from androgen dependence to androgen independence. To carry on a careful characterization of the phenotypes of CaP cell lines before and after acquisition of androgen independence, we used two human CaP LNCaP sublines: LNCaPnan, which is androgen dependent (AD), and LNCaP-HP, which is androgen independent (AI). In AD LNCaPnan cells, dihydrotestosterone (DHT) stimulated in an androgen receptor (AR)-dependent way a phosphorylation signaling pathway involving steroid receptor coactivator (Src)–mitogen-activated protein/extracellular signal-regulated kinase (ERK) kinase (MEK)-1/2–ERK-1/2–cAMP-response element binding-protein (CREB). Activation of this pathway was associated with increased [3H]thymidine incorporation and resistance to apoptosis. Use of dominant-negative forms of MEK-1/2 and CREB demonstrated in LNCaPnan cells that DHT induced [3H]thymidiine incorporation through a thus far unidentified molecule activated downstream of MEK-1/2, and antiapoptosis through phosphorylation of the transcription factor CREB. In contrast, in AI LNCaP-HP cells, the Src–MEK-1/2–ERK-1/2–CREB pathway was constitutively active. Because it was not further stimulated by addition of DHT, no increase of [3H]thymidine incorporation or apoptosis resistance was demonstrated in LNCaP-HP cells. Additional experiments showed that Src and the scaffold protein MNAR coimmunoprecipitated with AR, indicating a role for Src as an apical molecule in the Src–MEK-1/2–ERK-1/2–CREB pathway. Interestingly, differences between the two cell lines were that in LNCaP-HP cells presence of an AI phenotype and lack of response to DHT were associated with constitutive activation of the protein kinase Src and interaction among Src, AR, and MNAR. In contrast, in LNCaPnan cells, presence of an AD phenotype and ability to respond to DHT were associated with DHT-dependent activation of Src kinase activity and interaction among Src, AR, and MNAR. Intriguingly, in LNCaPnan cells, we found that transcription through the prototypical CREB-responsive promoter c-fos could be induced in a DHT-dependent way, and this action was inhibited by the AR antagonist Casodex and MEK-1 inhibitor PD98059. In contrast, transcription through the PSA P/E promoter, a prototypical AR-dependent promoter directly activated by agonist, was obliterated only by Casodex. Additional experiments with genital skin fibroblasts derived from patients with a variety of AR abnormalities indicated that nongenotropic AR signaling does not depend on an intact DNA-binding domain or on the ability of AR to translocate to the nucleus. The results suggest the following: (1) Constitutive activation of the Src–MEK-1/2–ERK-1/2–CREB pathway is associated with the AI phenotype observed in LNCaP-HP cells. (2) Activation of the Src–MEK-1/2–ERK-1/2–CREB pathway is DHT dependent in AD LNCaPnan cells. (3) DHT activation of this pathway is associated with induction of [3H]thymidine incorporation by a molecule activated downstream of MEK-1/2 and of antiapoptosis through activation of the transcription factor CREB in AD LNCaPnan cells. (4) AR regulates transcription either directly upon ligand binding and nuclear translocation or indirectly through kinase pathways leading to activation of downstream transcription factors. (5) Nuclear translocation and ability of the DNA-binding domain of AR to interact with DNA are not prerequisites for nongenotropic AR activity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-04-1121

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 61

  1. Cato AC, Nestl A, Mink S Rapid actions of steroid receptors in cellular signaling pathways. Sci Signal Transduction Knowledge Environment 2002;2002:RE9 · doi:10.1126/scisignal.1382002re9 · Paper page
  2. Szego CM, Davis JS Adenosine 3′,5′-monophosphate in rat uterus: acute elevation by estrogen. Proc Natl Acad Sci USA 1967;58:1711-8. · DOI · Paper page
  3. Falkenstein E, Tillmann HC, Christ M, Feuring M, Wehling M Multiple actions of steroid hormones: a focus on rapid, nongenomic effects. Pharmacol Rev 2000;52:513-56.
  4. Li X, Qiu J, Wang J, Zhong Y, Zhu J, Chen Y Corticosterone-induced rapid phosphorylation of p38 and JNK mitogen-activated protein kinases in PC12 cells. FEBS Lett 2001;492:210-4. · DOI
  5. Haseroth K, Gerdes D, Berger S, et al Rapid nongenomic effects of aldosterone in mineralocorticoid-receptor-knockout mice. Biochem Biophys Res Commun 1999;266:257-61. · DOI
  6. Migliaccio A, Di Domenico M, Castoria G, et al Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J 1996;15:1292-300. · DOI · Paper page
  7. Razandi M, Pedram A, Greene GL, Levin ER Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: studies of ERα and ERβ expressed in Chinese hamster ovary cells. Mol Endocrinol 1999;13:307-19. · DOI · Paper page
  8. Migliaccio A, Piccolo D, Castoria G, et al Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor. EMBO J 1998;17:2008-18. · DOI · Paper page
  9. Boonyaratanakornkit V, Scott MP, Ribon V, et al Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases. Mol Cell 2001;8:269-80. · DOI · Paper page
  10. Peterziel H, Mink S, Schonert A, Becker M, Klocker H, Cato AC Rapid signalling by androgen receptor in prostate cancer cells. Oncogene 1999;18:6322-9. · DOI · Paper page
  11. Migliaccio A, Castoria G, Di Domenico M, et al Steroid-induced androgen receptor-oestradiol receptor β-Src complex triggers prostate cancer cell proliferation. EMBO J 2000;19:5406-17. · DOI · Paper page
  12. Kousteni S, Bellido T, Plotkin LI, et al Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell 2001;104:719-30. · DOI · Paper page
  13. Lutz LB, Jamnongjit M, Yang WH, Jahani D, Gill A, Hammes SR Selective modulation of genomic and nongenomic androgen responses by androgen receptor ligands. Mol Endocrinol 2003;17:1106-16. · DOI
  14. Kousteni S, Han L, Chen JR, et al Kinase-mediated regulation of common transcription factors accounts for the bone-protective effects of sex steroids. J Clin Investig 2003;111:1651-64. · DOI
  15. Kousteni S, Chen JR, Bellido T, et al Reversal of bone loss in mice by nongenotropic signaling of sex steroids. Science 2002;298:843-6. · DOI · Paper page
  16. Zhu Y, Bond J, Thomas P Identification, classification, and partial characterization of genes in humans and other vertebrates homologous to a fish membrane progestin receptor. Proc Natl Acad Sci USA 2003;100:2237-42. · DOI · Paper page
  17. Zhu Y, Rice CD, Pang Y, Pace M, Thomas P Cloning, expression, and characterization of a membrane progestin receptor and evidence it is an intermediary in meiotic maturation of fish oocytes. Proc Natl Acad Sci USA 2003;100:2231-6. · DOI · Paper page
  18. McPhaul MJ, Marcelli M, Zoppi S, Griffin JE, Wilson JD Genetic basis of endocrine disease: 4. The spectrum of mutations in the androgen receptor gene that causes androgen resistance. J Clin Endocrinol Metab 1993;76:17-23. · doi:10.1210/jcem.76.1.8421085 · Paper page
  19. Kyprianou N, Isaacs J Activation of programmed cell death in the rat ventral prostate after castration. Endocrinology 1988;122:552-62. · DOI · Paper page
  20. Pollard M, Luckert PH, Sporn MB Prevention of primary prostate cancer in Lobund-Wistar rats by N-(4-hydroxyphenyl)retinamide. Cancer Res 1991;51:3610-1.
  21. Wu J-P, Fang-Liu G The prostate 41–65 years post-castration, an analysis of 26 eunuchs. Chin Med J 1987;100:271-2.
  22. Stanbrough M, Leav I, Kwan PW, Bubley GJ, Balk SP Prostatic intraepithelial neoplasia in mice expressing an androgen receptor transgene in prostate epithelium. Proc Natl Acad Sci USA 2001;98:10823-8. · DOI · Paper page
  23. Kazemi-Esfarjani P, Trifiro MA, Pinsky L Evidence for a repressive function of the long polyglutamine tract in the human androgen receptor: possible pathogenetic relevance for the (CAG)n-expanded neuronopathies. Hum Mol Genet 1995;4:523-7. · DOI · Paper page
  24. Giovannucci E, Stampfer MJ, Krithivas K, et al The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. Proc Natl Acad Sci USA 1997;94:3320-3.Erratum in: Proc Natl Acad Sci USA 1997;94:8272 · DOI · Paper page
  25. Hardy DO, Scher HI, Bogenreider T, et al Androgen receptor CAG repeat lengths in prostate cancer: correlation with age of onset. J Clin Endocrinol Metab 1996;81:4400-5. · doi:10.1210/jcem.81.12.8954049 · Paper page
  26. Zegarra-Moro OL, Schmidt LJ, Huang H, Tindall DJ Disruption of androgen receptor function inhibits proliferation of androgen-refractory prostate cancer cells. Cancer Res 2002;62:1008-13.
  27. Craft N, Shostak Y, Carey M, Sawyers C A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase. Nat Med 1999;5:280-5. · DOI · Paper page
  28. Marcelli M, Ittmann M, Mariani M, et al Androgen receptor mutations in prostate cancer. Can Res 2000;60:944-9.
  29. Nazareth L, Weigel N Activation of the human androgen receptor through a protein kinase A signaling pathway. J Biol Chem 1996;271:19900-7. · DOI · Paper page
  30. Culig Z, Hobish A, Cronauer MV, et al Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor I, keratinocyte growth factor, and epidermal growth factor. Cancer Res 1994;54:5474-8.
  31. Gregory CW, He B, Johnson RT, et al A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy. Cancer Res 2001;61:4315-9.
  32. Avila DM, Wilson CM, Nandi N, Griffin JE, McPhaul MJ Immunoreactive AR and genetic alterations in subjects with androgen resistance and undetectable AR levels in genital skin fibroblast ligand-binding assays. J Clin Endocrinol Metab 2002;87:182-8. · doi:10.1210/jcem.87.1.8166
  33. Zoppi S, Marcelli M, Deslypere J-P, Griffin JE, Wilson JD, McPhaul MJ Amino acid substitution in the DNA binding domain of the human androgen receptor are a frequent cause of receptor-binding positive androgen resistance. Mol Endocrinol 1992;6:409-15. · DOI
  34. Wilson CM, Griffin JE, Wilson JD, Marcelli M, Zoppi S, McPhaul MJ Immunoreactive androgen receptor expression in subjects with androgen resistance. J Clin Endocrinol Metab 1992;75:1474-8. · DOI
  35. Kim DW, Cheriyath V, Roy AL, Cochran BH TFII-I enhances activation of the c-fos promoter through interactions with upstream elements. Mol Cell Biol 1998;18:3310-20. · DOI
  36. Mansour SJ, Matten WT, Hermann AS, et al Transformation of mammalian cells by constitutively active MAP kinase kinase. Science 1994;265:966-70. · DOI · Paper page
  37. Jean D, Harbison M, McConkey DJ, Ronai Z, Bar-Eli M CREB and its associated proteins act as survival factors for human melanoma cells. J Biol Chem 1998;273:24884-90. · DOI · Paper page
  38. Wong CW, McNally C, Nickbarg E, Komm BS, Cheskis BJ Estrogen receptor-interacting protein that modulates its nongenomic activity-crosstalk with Src/Erk phosphorylation cascade. Proc Natl Acad Sci USA 2002;99:14783-8. · DOI · Paper page
  39. Janik P, Briand P, Hartmann NR The effect of estrone-progesterone treatment on cell proliferation kinetics of hormone-dependent GR mouse mammary tumors. Cancer Res 1975;35:3698-704.
  40. Mayr B, Montminy M Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol 2001;2:599-609. · DOI · Paper page
  41. Cooper JA, Esch FS, Taylor SS, Hunter T Phosphorylation sites in enolase and lactate dehydrogenase utilized by tyrosine protein kinases in vivo and in vitro. J Biol Chem 1984;259:7835-41. · DOI · Paper page
  42. Marcelli M, Haidacher SJ, Plymate SR, Birnbaum RS Altered growth and insulin-like growth factor binding protein-3 (IGFBP-3) production in PC3 prostate carcinoma cells stably transfected with a constitutively active androgen receptor cDNA. Endocrinology 1995;136:1040-8. · DOI
  43. Raffo A, Perlman H, Chen M-W, Day M, Streitman J, Buttyan R Overexpression of bcl-2 protects cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo. Cancer Res 1995;55:4438-45.
  44. Xing J, Ginty DD, Greenberg ME Coupling of the RAS-MAPK pathway to gene activation by RSK2, a growth factor-regulated CREB kinase. Science 1996;273:959-63. · DOI · Paper page
  45. De Cesare D, Jacquot S, Hanauer A, Sassone-Corsi P Rsk-2 activity is necessary for epidermal growth factor-induced phosphorylation of CREB protein and transcription of c-fos gene. Proc Natl Acad Sci USA 1998;95:12202-7. · DOI · Paper page
  46. Marcelli M, Cunningham G, Walkup M, et al Signaling pathway activated during apoptosis of the prostate cancer cell line LNCaP: overexpression of caspase-7 as a new gene therapy strategy for the treatment of prostate cancer. Cancer Res 1999;59:398-406.
  47. Tilley WD, Marcelli M, Wilson JD, McPhaul JM Characterization and cloning of a cDNA encoding the human androgen receptor. Proc Natl Acad Sci USA 1989;86:327-31. · DOI · Paper page
  48. Krishnan AV, Zhao XY, Swami S, et al A glucocorticoid-responsive mutant androgen receptor exhibits unique ligand specificity: therapeutic implications for androgen-independent prostate cancer. Endocrinology 2002;143:1889-900. · doi:10.1210/endo.143.5.8778
  49. Castoria G, Lombardi M, Barone MV, et al Androgen-stimulated DNA synthesis and cytoskeletal changes in fibroblasts by a nontranscriptional receptor action. J Cell Biol 2003;161:547-56. · DOI
  50. Muthuswamy SK, Siegel PM, Dankort DL, Webster MA, Muller WJ Mammary tumors expressing the neu proto-oncogene possess elevated c-Src tyrosine kinase activity. Mol Cell Biol 1994;14:735-43. · DOI
  51. Rosen N, Bolen JB, Schwartz AM, et al Analysis of pp60c-src protein kinase activity in human tumor cell lines and tissues. J Biol Chem 1986;261:13754-9. · DOI · Paper page
  52. Ottenhoff-Kalff AE, Rijksen G, van Beurden EA, et al Characterization of protein tyrosine kinases from human breast cancer: involvement of the c-src oncogene product. Cancer Res 1992;52:4773-8.
  53. Egan C, Pang A, Durda D, Cheng HC, Wang JH, Fujita DJ Activation of Src in human breast tumor cell lines: elevated levels of phosphotyrosine phosphatase activity that preferentially recognizes the Src carboxy terminal negative regulatory tyrosine 530. Oncogene 1999;18:1227-37. · DOI
  54. Gioeli D, Mandell JW, Petroni GR, Frierson HF, Jr, Weber MJ Activation of mitogen-activated protein kinase associated with prostate cancer progression. Cancer Res 1999;59:279-84.
  55. Price DT, Rocca GD, Guo C, Ballo MS, Schwinn DA, Luttrell LM Activation of extracellular signal-regulated kinase in human prostate cancer. J Urol 1999;162:1537-42. · doi:10.1016/s0022-5347(05)68354-1
  56. Bakin RE, Gioeli D, Sikes RA, Bissonette EA, Weber MJ Constitutive activation of the Ras/mitogen-activated protein kinase signaling pathway promotes androgen hypersensitivity in LNCaP prostate cancer cells. Cancer Res 2003;63:1981-9.
  57. Bakin RE, Gioeli D, Bissonette EA, Weber MJ Attenuation of Ras signaling restores androgen sensitivity to hormone-refractory C4–2 prostate cancer cells. Cancer Res 2003;63:1975-80.
  58. Voeller H, Wilding G, Gelmann E v-rasH expression confers hormone-independent in-vitro growth to LnCAP prostate carcinoma cells. Mol Endocrinol 1991;5:209-16. · DOI
  59. Foulkes NS, Sassone-Corsi P Transcription factors coupled to the cAMP-signalling pathway. Biochim Biophys Acta 1996;1288:F101-21. · DOI
  60. Iordanov M, Bender K, Ade T, et al CREB is activated by UVC through a p38/HOG-1-dependent protein kinase. EMBO J 1997;16:1009-22. · DOI · Paper page
  61. Rowan BG, Weigel NL, O’Malley BW Phosphorylation of steroid receptor coactivator-1: identification of the phosphorylation sites and phosphorylation through the mitogen-activated protein kinase pathway. J Biol Chem 2000;275:4475-83. · DOI · Paper page

Cited by

See all 229

Metadata

Authors
Unni, E., Sun, S., Nan, B., McPhaul, M. J., Cheskis, B., Mancini, M. A., & Marcelli, M.
Venue
Cancer Research
Published
2004-10-01
Volume
64
Issue
19
Pages
7156-7168
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2117638862
Cited by
229
References
9
FWCI
16.14
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Changes in Androgen Receptor Nongenotropic Signaling Correlate with Transition of LNCaP Cells to Androgen Independence. https://app.cochat.ai/papers/10.1158/0008-5472.can-04-1121
The paper
Unni, E., Sun, S., Nan, B., McPhaul, M. J., Cheskis, B., Mancini, M. A., & Marcelli, M. (2004). Changes in Androgen Receptor Nongenotropic Signaling Correlate with Transition of LNCaP Cells to Androgen Independence. Cancer Research. https://doi.org/10.1158/0008-5472.can-04-1121

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.